HLB Life Science Co., Ltd. (KOSDAQ: 067630)
South Korea
· Delayed Price · Currency is KRW
9,360.00
-990.00 (-9.57%)
Oct 11, 2024, 9:00 AM KST
HLB Life Science Revenue
HLB Life Science had revenue of 23.58B KRW in the quarter ending June 30, 2024, with 10.04% growth. This brings the company's revenue in the last twelve months to 92.87B, down -22.84% year-over-year. In the year 2023, HLB Life Science had annual revenue of 97.99B, down -1.61%.
Revenue (ttm)
92.87B
Revenue Growth
-22.84%
P/S Ratio
10.64
Revenue / Employee
654.01M
Employees
142
Market Cap
1,110.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 97.99B | -1.60B | -1.61% |
Dec 31, 2022 | 99.59B | 46.10B | 86.17% |
Dec 31, 2021 | 53.49B | -38.30B | -41.73% |
Dec 31, 2020 | 91.80B | -22.22B | -19.49% |
Dec 31, 2019 | 114.02B | 11.54B | 11.26% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition